| Title |
Premarket Safety and Efficacy Studies for ADHD Medications in Children
|
|---|---|
| Published in |
PLOS ONE, July 2014
|
| DOI | 10.1371/journal.pone.0102249 |
| Pubmed ID | |
| Authors |
Florence T. Bourgeois, Jeong Min Kim, Kenneth D. Mandl |
| Abstract |
Attention-deficit hyperactivity disorder (ADHD) is a chronic condition and pharmacotherapy is the mainstay of treatment, with a variety of ADHD medications available to patients. However, it is unclear to what extent the long-term safety and efficacy of ADHD drugs have been evaluated prior to their market authorization. We aimed to quantify the number of participants studied and their length of exposure in ADHD drug trials prior to marketing. |
X Demographics
The data shown below were collected from the profiles of 31 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 7 | 23% |
| United Kingdom | 3 | 10% |
| Netherlands | 1 | 3% |
| Spain | 1 | 3% |
| Australia | 1 | 3% |
| Unknown | 18 | 58% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 24 | 77% |
| Practitioners (doctors, other healthcare professionals) | 4 | 13% |
| Scientists | 3 | 10% |
Mendeley readers
The data shown below were compiled from readership statistics for 60 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | 2% |
| United States | 1 | 2% |
| Netherlands | 1 | 2% |
| Germany | 1 | 2% |
| Unknown | 56 | 93% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 11 | 18% |
| Other | 7 | 12% |
| Student > Ph. D. Student | 7 | 12% |
| Professor > Associate Professor | 6 | 10% |
| Student > Doctoral Student | 5 | 8% |
| Other | 15 | 25% |
| Unknown | 9 | 15% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 16 | 27% |
| Psychology | 12 | 20% |
| Computer Science | 4 | 7% |
| Nursing and Health Professions | 3 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 5% |
| Other | 10 | 17% |
| Unknown | 12 | 20% |